MedPath

Dobugen

Brand Name: Dobugen

Generic Name: Dobutamine (as Hydrochloride)

Active
Registration Number

DR-XY43891

Dosage Form

Solution For Injection (Iv)

Issuance Date

May 31, 2024

Expiry Date

November 18, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50mg/mL (250mg/5mL)
PackagingUSP Type I Glass Ampoule x 5mL (Box of 10's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Adrenergic Agent
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Dobutamine (as Hydrochloride)Active
Monograph: dobutamine (as hydrochloride)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.